Delayed doxorubicin induced cardiomyopathy in a breast cancer patient: A case report

Delayed doxorubicin induced cardiomyopathy in a breast cancer patient: A case report

Heart failure (HF) is a clinical syndrome with a wide spectrum of presentations and an even wider array of etiologies. Anthracyclines such as Doxorubicin, Daunorubicin, Idarubicin, and Epirubicin have demonstrated increased risk of HF with significant morbidity and mortality. We present an interesti...

Full description

Bibliographic Details
Main Authors: David Song, DO, Jawad Shabani, MD, Vikash Jaiswal, MD, Matthew Cagliostro, MD, MPH, David Rubinstein, MD, M. Chadi Alraies, MD
Format: Article
Language:English
Published: Elsevier 2023-03-01
Series:Radiology Case Reports
Subjects:
Chemotherapy
Doxorubicin
Breast cancer
Heart failure
Cardiomyopathy
Online Access:http://www.sciencedirect.com/science/article/pii/S1930043322011189

Internet

http://www.sciencedirect.com/science/article/pii/S1930043322011189

Similar Items